Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes, your SGMA, and my OROCF and GALXF.
...and you base your statement on your statistical expertise of course.
Please....
Good news from Australia regarding gold exploration:
Highlights (Credit to able77 from HC)
• Processing and interpretation of recently completed 3,900 line km airborne geophysical survey data
identifies 16 anomalies for drill testing at Mt Dove and Deep Well gold projects, WA
• Identification of discrete magnetic anomalies under cover, advancing exploration for Hemi-style
intrusion-related gold mineralisation
• Newly pegged Mac Well tenement, E45/5904, increases gold holdings in Hemi district to 911 sq km
https://hotcopper.com.au/threads/ann-magnetic-drill-targets-identified-at-pilbara-gold-projects.6055202/?get_post=true
Loved the reminder about Adam F, thanks!
Don’t forget California, which is not going to stay at 4 dispensaries, and one appears to be in Venice Beach, which is like the Mecca of MJ in SoCal.
I love this deal long term and will buy more shares if we get a dip in the near term.
Yep, revenue coming and leronlimab saving lives.
Most here will celebrate, a few will panic, cry and come up with new stories..
Oh well....
I noticed that HARV has 4 dispensaries in my State (CA). This is a good start and I am sure that many more will open so the total number of dispensaries in California will approach or exceed the number in Arizona. Trulieve will continue to dominate in Florida, but politics there are making it difficult for recreational and MJ in general. I appreciate how quickly Kim Rivers realized the need to expand to other States. Our Queen Bee executed quickly and with no hesitation. Great move!
...disagree, but I am sure you are seeing my number every day.
Yes, we will go for 10 to 100, and to eventually 1000 hospitals or thereabouts.
Each multiplied by 100, wow!
Nope, longs only have to be right once.
Excellent point, thank you Learning53!
Yep. Take the example of BWA. He did a remarkable job with his stock price predictions and nailed many along with excellent insights. He then went into this type of cryptic messaging, and I lost interest in his posts. I sense that he is now starting to go back to providing better insights without wild speculation, which I appreciate.
“ The entire hospital has permission to give leronlimab to patients. ”
I love the sound of that! We just need to multiply by number of hospital. Start with 10, then 100 and eventually 1000 or thereabouts...
Agree, This type of cryptic posting to raise expectations does not work for me. I don’t think it helps this Board either. Oh well....
“Efficacious drugs have side effects because they are having a big effect on the patient's system. Leronlimab's efficacy is probably similar to the efficacy of herbal remedies.”
Mitch Ochoa is the young man that appeared today in Cito Beltrán’s show. I am sure that he would tell you that leronlimab was quite efficacious for him. The drug’s effect was BIG and beneficial, and definitely not a herbal tea. You may want to contact him since you seem to question the drug’s benefits. It would not surprise me that some witl try to question Mr. Ochoa’s and other survivors’ reputations and judgment. They will also keep going with the condescending comments towards the drug calling it salty water, etc. It is naive and disrespectful, but it is also I expect it as part of the process. I actually laugh, because it makes no difference to the the longs, the patients and the doctors. Leronlimab will save many more lives like Mr. Ochoa. God bless him and all future patients.
Agree. It was nice to see how appreciative the survivor (Mitch Ochoa) was about leronlimab. He stated that he began improving within 24:hours after taking the first shot and and even more in the following day. He described specific improvements in heart rate, oxygen saturation and stated that he has no long hauler type effects.
Yes Diesel, an obvious case of flip-flopping and bitterness. I guess we should interpret his post in Opposite Day mode.
Thanks for the reminder!
First of all, it is a combination of many factors as my post indícated. The attention here and elsewhere are simply the result of people recognizing that Leronlimab is the top therapeutic. This sentiment is shared by many top doctors and researchers throughout the world. We will hear hear today and this week about revenues and the 27 in Phillipines, and soon from the studies in Brazil. By the way, The Medical Center in Sao Paolo is ranked number one in Brazil and is among the top 10-20 medical centers in the world. It will result in top notch studies, which will facilitate approvals and a possible buyout. And yes, we even have a MDs in the frontlines and experienced longs here that are know that this wonder drug is the real deal. Shorters will continue with their agendas, but most here will take the opinions from misiu, Rockleo and others any day over yours. Get ready for a rude awakening.
Can’t wait to hear about revenues, the 27 and Brazil!
Get ready shorty....
Yes true and obvious. Leronlimab has prevailed despite all the attacks from shorters and games from regulators. If Leronlimab had no value, it would not be in the news, the SP would be much lower, and we would not be talking about it. Instead, this and other sites are full of daily comments, the SP continues to be around $3, and many pertinent developments are taking place. Catalysts in Phillipines, Brazil and elsewhere will trigger very soon. The market understands Leronlimab’s intrinsic value as the best therapeutic available and its great potential for multiple indications. It is evident that the shorters are in denial and have their blinders on, but longs are well aware thar they have a wonder drug that will save many lives.
Leronlimab will prevail.
This is excellent news! The Quebec authorities are finally realizing that they need to streamline the process. Getting the BAPE soon coupled with the news of Sayona Board members buying shares suggest that we may get good NAL news soon.
Thanks!
I am just catching up with the last two days of information. Thanks for the great posts as I think we are looking good!
Prof. pay no attention to bitter individuals with seller’s remorse...
Much better to focus on what’s coming from Phillipines and Brazil. I am even considering buying Rosetta Stone to learn a bit of Tagalo; my Portuguese is decent...
LONG CYDY!
Getting Cura... would be awesome, but it may take some time.
Phillipines will open the door for revenues, and for excellent news from the 27 and many more.
Brazil’s studies will open the door for further confirmation of efficacy in different groups of patients and in more revenues.
Together, these efforts will result in approvals and/or a very nice buyout, so that Leronlimab will save many more lives.
The door will close on the shorters, who are not sleeping well lately....
I will try getting it for you unless someone here has it handy.
Sorry to break it to you buddy, but the joke will be on you in a couple of weeks.
I am afraid that people are going to keep asking about dosages and vial sizes for weeks.
Misiu, you have more patience and endurance than Job from the Bible!
It often takes time for the market to fully digest and understand companies’ news, especially when there are complexities like in pharmaceutical companies with protocols, stats, etc. This has happened several times before to CYDY, and two major news events this week are no exceptions to this tendency. i think it is best to describe each event in simple terms in order to help process and appreciate the power of the information they contain:
1) CYDY will be receiving considerable revenue from Phillipines and Leronlimab will save many lives there. This model can easily be applied to other countries.
2) CYDY will be conducting two major studies in Brazil using the top protocols in coordination with the best hospital in Brazil and support from BIOMM. This will help enroll patients quickly, provide timely interim results, confirm efficacy in final results, and open the door to approvals and/or buyout proposals from a large BP companies, which is perhaps the most important factor along with the good PR from saving lives.
Both news are epic. In my opinion, they are among the top 5 most relevant news events in the history of CYDY. It will still take a few days for the market to fully digest these news, as it may be waiting for further confirmation and catalysts (details on first revenues, status of 28 patients, details on Brazil studies). This will eventually happen as more information is released within the next couple of weeks., The good news will start spreading and the SP will rise accordingly. Long investors and investors in the sidelines know this and are closely watching the SP dip as these events unfold. They are ready to buy cheap shares at the right time. In my case, I have already placed my buy orders, as I see this as an excellent opportunity to accumulate additional cheap shares before CYDY takes off.
This is a great finding.
Thank you misiu!
I would recommend you contact Dr. Kelly directly in addition to using the website. I hope she gets better.
Yep, the support at $15 Canadian or $12 US is looking shaky, so let’s hope for a rebound. If not, I am afraid that we may get to the next support under $10 US. My current average is under $8 US and I am already using free money due to many good swing trades in the past. Nevertheless, I am not too happy, especially when we were well over $20. Long term investment, but yikes!
That is correct. We will get confirmation of the first sales to the Phillipines in 1-2 weeks. It will probably be around 10k to 20k vials, which will provide around $7M to $14M. The orders will keep gradually coming after that until we reach the 200k vials that Cytodyn set aside for Phillipines for a total revenue around $140M. Granted, we may see some differences in number of vials, price, etc. Nevertheless, I think it is safe to assume that we will get $5M to $10M from the first revenues and $50M to $100M total. Not bad if you ask me. It is a given that shorty will say that the sky is falling and try to turn this forum into a circus, and that’s ok by me. Their antics may drive the SP to new dips, but these are opportunities for longs to buy more shares. Then, Brazil will add and extra boost with its two studies, which may facilitate a buyout.
Revenues are coming and Leronlimab will save many lives.
The haircuts keep coming...
Plus it is possible that very sick patients may receive 4 weeks of treatment or double the amount you mentioned, correct?
We put BlackOps. It is difficult to understand how a few are against a life saving drug. Sad...
Let’s not beat around the bush, many millions in revenues coming this quarter. The shorters are getting extra nervous, because they know it and there is nothing they can do about it. I am not concerned about the SP tomorrow, this week or even next. We will be in double digits in a few months, and I think I am being conservative.
Sleep well shorts....
Well, you will then have to wait an extra week to rejoice with the rest of us. Your patience will be rewarded.
I was just reading a similar article in Yahoo, wow!
I am going to start feeling sorry for Gates, Fauci and others in their gang....